SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51678Can you explain? ArtArt Bechhoefer-3/11/2021
51677Anyone follow/have opinions on SESN? Seems to be a nice set up, funding and manoldirtybastard-3/11/2021
51676I doubt it Art. I think the hang-up may be AZN/FGEN pushing for delay of dialysiJoe Wesley-3/11/2021
51675After further investigation, I believe my original position on this issue is morArt Bechhoefer-3/11/2021
51674". . . they are not going to accept judgement from experts chosen by foreigArt Bechhoefer-3/11/2021
51673Fueurstein reported on criticisms and asked a question. The FDA has long insistA.J. Mullen13/11/2021
51672It doesn't surprise me that politics interferes with recognized procedures fArt Bechhoefer-3/11/2021
51671NOV Inclisiran rejection was a surprise too.JamesK-3/11/2021
51670There have been a number of articles recently suggesting the FDA's recent coA.J. Mullen-3/10/2021
51669The NYT link you provided is the correct one. The article notes that normally sArt Bechhoefer23/9/2021
51668The New York Times article is self explanatory. It would help if you'd posA.J. Mullen13/9/2021
51667As I've noted many times before, I've seen a lot of stuff going on at thArt Bechhoefer-3/9/2021
51666…the FDA didn't need to bother with the advisory committee meeting because tDewDiligence_on_SI13/9/2021
51665The implication in my first comment was that the FDA didn't need to bother wArt Bechhoefer-3/9/2021
51664That doesn't address my question about the scheduling of an advisory committDewDiligence_on_SI-3/9/2021
51663The answer to your question is contained in the NYT article: They won't appArt Bechhoefer13/9/2021
51662FGEN—I do not understand your reasoning. Why would the FDA’s inability to conducDewDiligence_on_SI-3/9/2021
51661Why did the FDA delay approval of FibroGen's roxadustat? A possible, and veArt Bechhoefer13/9/2021
51660Nvidia, Harvard researchers use AI to find active areas in cell DNA zdnet.comFrank Sully23/8/2021
51659Conflicts of interest that affect FDA decision-making are pretty rare, in my expDewDiligence_on_SI-3/5/2021
51658The FDA delayed approval of a drug for atrial fibrillation, while approving a coArt Bechhoefer23/5/2021
51657"pressure on the FDA decision on a new drug by the makers of competing drugdiegosan-3/5/2021
51656Yes, it's back to where it was four months ago. Those that rose fast are faA.J. Mullen-3/5/2021
51655CRSP has dropped in half the last two months. Biotech bubble finally has a pinprJamesK-3/5/2021
51654I was more aggressive than that. I sold puts with a $40 strike and expiration nArt Bechhoefer-3/2/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News